Open AccessPrevention of bisphosphonate osteonecrosis in dental patient with osteoporosis
Author(s) -
Д. В. Стоматов,
Yu. V. Efimov,
А. В. Стоматов,
Е Ю Ефимова,
А.А. Нестеров
Publication year - 2020
Publication title -
medicinskij alfavit
Language(s) - English
Resource type - Journals
eISSN - 2949-2807
pISSN - 2078-5631
DOI - 10.33667/2078-5631-2019-4-34(409)-5-6
Subject(s) - medicine , osteonecrosis of the jaw , osteoporosis , bisphosphonate , seriousness , psychological intervention , dentistry , bisphosphonate associated osteonecrosis of the jaw , drug administration , intensive care medicine , family medicine , nursing , political science , law
The analysis of scientific literature on the use of bisphosphonates in the treatment of osteoporosis. This effective group of drugs was included in the first line of appointments by specialists dealing with the problem of osteoporosis. At the same time, a number of authors associate the appearance of medicinal osteonecrosis of the jaws, called BONJ (bisphosphonate osteonecrosis of the jaws), in patients with the administration of bisphosphonates. One of the triggering mechanisms of the emergence of BONJ are surgical dental interventions performed in patients receiving bisphosphonates. Today, patients may not understand the seriousness of taking these drugs and often do not warn the dentist before manipulation, as well as not all dentists attach importance to the danger of drugs from osteoporosis. In this paper, based on the analysis of scientific literature, the attention of dentists to the problem of possible complications in the treatment of patients with osteoporosis, taking bisphosphonates. A questionnaire included in the questionnaire of a dental patient, taking into account the name of the drug and the duration of its administration, is proposed.